Stocks and Investing Stocks and Investing
Wed, May 30, 2018
Tue, May 29, 2018

Matthew Harrison Initiated (UBX) at Buy and Held Target at $250 on, May 29th, 2018


Published on 2024-10-26 05:47:01 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Initiated "Unity Biotechnology, Inc." (UBX) at Buy and Held Target at $250 on, May 29th, 2018.

Matthew, nor any peers, have made any analyst calls on UBX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources